Profile
Cedric Burg worked as the Vice President of Global Clinical Development at Chiltern International Ltd. He also held the position of Vice President and Head of Global Clinical Operations at BioXcel Therapeutics, Inc. Prior to these roles, he served as the Chief Operating Officer at Innovaderm Research, Inc. Dr. Burg completed his undergraduate degree at American University.
He then pursued a graduate degree at the University of Rennes and obtained a doctorate degree from the University of Nantes.
Former positions of Cedric Burg
| Companies | Position | End |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Innovaderm Research, Inc.
Innovaderm Research, Inc. BiotechnologyHealth Technology Operates as a clinical research organization specialized in dermatology | Chief Operating Officer | - |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | - |
Training of Cedric Burg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rennes
University of Rennes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Nantes
University of Nantes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovaderm Research, Inc.
Innovaderm Research, Inc. BiotechnologyHealth Technology Operates as a clinical research organization specialized in dermatology | Health Technology |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
- Stock Market
- Insiders
- Cedric Burg
















